The ASCI is pleased to announce a partnership with Genentech to support early-career physician scientists.
The Genentech / ASCI Early-Career Impact Awards program seeks to enhance the understanding of disease mechanisms, accelerate translational discoveries, and drive the development of cutting-edge diagnostics and therapies. These Awards support the work of physician-scientists who are early in their first full-time faculty appointment and who are conducting impactful research in one of Genentech’s therapeutic areas of interest.
- Number of available awards: up to 2
- Award amount: $100,000 per year for 3 years, with an institutional match of $100,000 per year for 3 years
- Nomination deadline: April 20, 2026, 11:59 pm Eastern
- Start of Award: July 1, 2026
Eligible nominees:
- are from an U.S.-accredited university / research institution that is able to commit to matching the award amount of $100,000/year for 3 years,
- hold an MD, MD/PhD, or equivalent degree,
- be in the first three years of their first academic appointment at the Instructor or Assistant Professor or equivalent level (tenure- and non-tenure-track) as of the Award start date,
- can dedicate more than 75% of their time to research activities,
- conduct research in one of Genentech’s therapeutic areas of interest:
- Cardiovascular, renal, and metabolic disease
- Immunology
- Infectious disease
- Neuroscience
- Oncology
- Ophthalmology
- and are in good standing at their institution.
Nominees are nominated by an ASCI member, who does not have to be from the nominee’s institution. The ASCI Directory is linked here (searchable by name, institution, specialty, etc.).
- Nominators:
- start nominations through their ASCI member accounts, under the “Activities / nominations” tab
- send notification to the nominee to complete the nominee’s aspects of the nomination
- submit a 500-word summary of the nominee’s accomplishments
- Nominees submit documents and other information through the ASCI website (nominees who have not yet identified a nominator may request that ASCI staff initiate the nomination, see contact email below):
- Documents:
- letter of commitment from their institution regarding the institutional funding match (PDF) (see More information, below)
- a comprehensive research plan (1,000-word limit, excluding preliminary results and references), using an editable template (Word):
- Project title
- Background
- Hypothesis
- Methods
- Aims 1-3 (rationale, experiment, expected outcomes)
- Preliminary results (if applicable) (not included in word count)
- Timeline
- References (not included in word count)
- curriculum vitae
- NIH-style biosketch
- photo (for use if awarded, not used during the review process)
- Other information about themselves, including contact, educational background, research domain(s), brief biographical statement, and demographic details
In addition to financial support, award benefits include:
- Complimentary registration to the AAP/ASCI/APSA Joint Meeting
- Access to ASCI Early-Career programming
For questions, contact staff@the-asci.org.
More information
Restrictions on the use of Award funds
- This program does not provide, and is not intended to cover, indirect costs. Funds should be used to support salaries for the Awardee, post-doctoral fellows or graduate students as well as supplies required in the performance of the research proposal. Funds may not be used to purchase major equipment or engage in non-research activities such as time spent as a healthcare provider.
Institutional funding match
- Use of start-up funds. Start-up funds may be used to match the Award amount, provided that such funds are available through the term of this Award. A letter of commitment specifying this must still be supplied.
- Coverage of indirect costs. Institutional funds may be used to cover indirect costs.
- Letter of commitment. This may be from the nominee’s department chair, dean, or equivalent.
Concurrent funding
- Concurrent funding, including career-development awards (NIH K and similar) and project awards (NIH R and similar) is allowed.
